Home self-administration of omalizumab for chronic spontaneous urticaria
- 27 October 2016
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 175 (6), 1405-1407
- https://doi.org/10.1111/bjd.15074
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled StudyJournal of Investigative Dermatology, 2015
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapyJournal of Allergy and Clinical Immunology, 2013
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous UrticariaThe New England Journal of Medicine, 2013